RT Journal Article
SR Electronic
T1 Polymorphism of the glucocorticoid receptor gene (NR3C1) in chronic illnesses: a protocol of a scoping review
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.07.31.20166108
DO 10.1101/2020.07.31.20166108
A1 Y Sguassero
A1 G Gallucci
A1 O Bottasso
YR 2020
UL http://medrxiv.org/content/early/2020/08/04/2020.07.31.20166108.abstract
AB During process like local or systemic homeostatic disturbances due to infection, tissue injury, trauma or surgery, neoplastic growth or immunological disorders, the host responds with a defensive reaction, the acute phase response, which encompasses alterations in immune, metabolic, neuroendocrine functions. Beyond the triggering stimulus, innate immune cells, quickly manage to deal with such a threat and secrete proinflammatory cytokines like Tumour Necrosis Factor alpha (TNF-α), Interleukin 1 beta (IL-1β), and Interleukin 6 (IL-6). Beyond their immunological effects, these cytokines also activate the stress system within the central nervous system leading to the activation of the hypothalamic-pituitary-adrenal axis as an effectors arm. As such, the immune response mounted against pathogens is paralleled by a significantly altered hormonal response. In relation to the immunomodulatory influences of adrenal steroids, glucocorticoids (GCs) suppress the immune system at several levels, avoiding the possible adverse effects of an excessive immune response and helping to terminate it once the noxious stimulus was eliminated. Under some circumstances, particularly at the beginning of the immune response, GCs can also exert pro-inflammatory effects. But at high concentrations, GCs generally suppress immune and inflammatory responses arising during activation of innate and adaptive immune responses. As in many physiological processes, individual sensitivity to GCs is variable being determined by genetic and acquired factors. This kind of versatility of GCs effects, that also extends to immune cells, may be due to a series of mechanisms, including a familiar resistance linked to inactivating mutations of GR or SNP -Single Nucleotide Polymorphism-functions affecting transcription. In this context, we will conduct a Scoping Review (ScR) of the literature about SNPs in the glucocorticoid receptor gene (NR3C1).The general aim of this ScR is to examine the extent and nature of available evidence on chronic illnesses associated with SNPs in the glucocorticoid receptor gene. The scoping review will assess evidence from all observational study designs. We will conduct a search in MEDLINE and LILACS. No language restriction will be applied. We will also search The Cochrane Library, and Epistemonikos to identify systematic reviews as an additional mechanism to identify primary studies. These searches will aim to identify all articles related to SNPs in the GR gene and will not be restricted to those evaluating specific conditions. These searches will be supplemented by scanning references of relevant retrieved articles to identify any additional relevant studies. References will be screen by titles and abstracts, remaining potentially relevant articles will be screen as full texts. Two reviewers will independently screen all identified records for relevance. Conflicts between reviewers will be solved by consensus or by the lead systematic reviewer in consultation with the content experts, if required. We will create a diagram to show the number of studies in each population condition. One reviewer will chart the data using pre-tested data-charting forms. This data charting will be double-checked for accuracy by a second reviewer. We will resolve any disagreements about data extraction by referring to the study report and through discussion. Once data is charted for all included studies, we will tabulate the data for each new condition identified. Findings from the scoping reviews will be reported according to the newly developed, PRISMA for Scoping Reviews (PRISMA-ScR). When interpreting the review findings, we will make sure that the limitations of different study designs are carefully considered, though no quality assessment will be performed.Competing Interest StatementYanina Sguassero has no conflict of interest to declare. Georgina Gallucci has received a grant from the Fund for Scientific and Technological Research FONCyT (PICT 2016-0279), the Foundation for Medical Sciences of Rosario, and the Secretariat for Science and Technology of the National University of Rosario, Argentina. In no situation, the funder agency had any influence on the results of the work. Oscar Bottasso is a senior researcher from The National Council of Scientific and Technological Research and the National University of Rosario, Argentina. Funding StatementThis work was supported by grants from the Fund for Scientific and Technological Research FONCyT (PICT 2016 0279), the Foundation for Medical Sciences of Rosario, and the Secretariat for Science and Technology of the National University of Rosario, Argentina.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This protocol does not report on or involve the use of any animal or human data or tissue. Ethics approval was not required.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThis is a retrospective study and aggregate data will be extracted from published papers.